Lyon, France – October 20, 2025 – EDAP TMS SA (Nasdaq: EDAP) (“EDAP” or the “Company”), a global leader in robotic, energy-based therapeutic technologies, today announced that it has entered into a €36 million multi-tranche credit facility (the “Credit Facility”) with the European Investment Bank (the “EIB”). Proceeds from the financing will be used to support the continued global expansion of the Company’s Focal One Robotic High-Intensity Focused Ultrasound (HIFU) platform.
The funds will also accelerate the development of new clinical indications for the Company’s innovative HIFU technology.
EDAP expects to draw the first tranche of €11 million under the Credit Facility in the fourth quarter of 2025.
